ArticlePharmaceutics2023

Anti-Tumor Activity of Orally Administered Gefitinib-Loaded Nanosized Cubosomes against Colon Cancer.

Ahmed A El-Shenawy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.